Pure Global

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia - Trial NCT05879133

Access comprehensive clinical trial information for NCT05879133 through Pure Global AI's free database. This phase not specified trial is sponsored by M.D. Anderson Cancer Center and is currently Recruiting. The study focuses on Chronic Lymphocytic Leukemia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05879133
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05879133
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

Study Focus

Questionnaires

Interventional

behavioral

Sponsor & Location

M.D. Anderson Cancer Center

Houston, United States of America

Timeline & Enrollment

N/A

May 17, 2023

Jul 03, 2025

30 participants

Primary Outcome

Functional Assessment of Cancer Therapy (FACT) questionnaires.

Summary

To learn if exercise and weight management can help to improve feelings of fatigue in CLL
 survivors.

ICD-10 Classifications

Chronic lymphocytic leukaemia of B-cell type
Chronic myelomonocytic leukaemia
Acute myelomonocytic leukaemia
Lymphoid leukaemia
Chronic leukaemia of unspecified cell type

Data Source

ClinicalTrials.gov

NCT05879133

Non-Device Trial